Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...

A pioneering study has provided unprecedented insights into the immune response following pig-to-human kidney ...

Kidney transplant recipients who receive donor-derived hematopoietic stem cells may be able to discontinue immunosuppressive ...

DelveInsight's “Kidney Transplant Rejection Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of kidney transplant rejection, historical ...

Scientists tracked how human immune cells attack pig kidneys after transplant—and found a way to fight back using precision ...

Sanofi's riliprubart gets FDA orphan drug status for organ transplant rejection, unlocking key development perks.

Study indicates iMDx flagship technology’s equivalence with commercially available dd-cfDNA test kitsHead-to-head comparison of iMDx’s digital PCR-based test kits with NGS kits shows ...

While immunosuppressive medications are critical to prevent rejection of transplant organs, they also come with plenty of downsides.

Research shows that small extracellular vesicles shed by donor heart cells and circulating T cells provide a precise readout ...

This positive data supports iMDx's top priority of launching its first clinical molecular diagnostic test kit and capturing value in the estimated $1 billion transplant rejection testing market.

Explore the latest advances in immunosuppression research that may bring transplant patients closer to the goal of having "one organ for life". Learn about new developments in organ transplant and ...